| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.053 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |